Abbott Laboratories vs. Eledon Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$97.50 +0.84%
VS ELDNEledon Pharmaceuticals, Inc. Common Stock
$2.78 -1.42%
Abbott Laboratories and Eledon Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | ELDN | |
|---|---|---|
| Market Cap | $168.71 billion | $229.16 million |
| Net Income (TTM) | — | $-98,561,000 |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | ELDN | |
|---|---|---|
| Price / Book | — | 6.94 |
ABT and ELDN split the valuation factors evenly.
Profitability
| ABT | ELDN | |
|---|---|---|
| Return on Equity | — | -298.55% |
ABT and ELDN split the profitability factors evenly.
Dividend
| ABT | ELDN | |
|---|---|---|
| Dividend Yield | 2.58% | — |
ABT and ELDN split the dividend factors evenly.
Risk & Sentiment
| ABT | ELDN | |
|---|---|---|
| Short Interest | 0.57% | 0.11% |
ELDN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ELDN overview, ELDN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.